Romańska-Knight Hanna, Abel Paul
Department of Molecular Pathology and Neuropathology, Medical University of Łódź, Poland.
Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London, Great Britain.
Cent European J Urol. 2011;64(4):196-200. doi: 10.5173/ceju.2011.04.art1. Epub 2011 Dec 9.
The Cancer Stem Cells (CSCs) hypothesis postulates that a minute subpopulation of cells is accountable for cancer initiation and progression. Unlike the stochastic and clonal evolution models, the CSC theory proposes that tumours are hierarchical and only the rare subset of cells at the top of the 'stemness hierarchy tree' are adequately 'equipped' biologically to initiate and drive tumourigenesis. CSCs have been implicated in various solid malignancies including prostate cancer (PCa), where their existence seems to provide an explanation for the failure of tumour eradicating therapies. As CSCs are thought to share many properties with normal stem cells, understanding normal stem cells should shed light on the pathomechanisms of cancer and, importantly, on potential therapeutic interventions. The purpose of this paper is to review the existing data on CSCs in PCa, their putative phenotypic markers, potential role in tumour biology and relevance to therapy.
癌症干细胞(CSCs)假说假定,一小部分细胞是癌症起始和进展的原因。与随机和克隆进化模型不同,CSC理论提出肿瘤具有层级结构,只有“干性层级树”顶端的罕见细胞亚群在生物学上具备启动和驱动肿瘤发生的充分“条件”。CSCs已被认为与包括前列腺癌(PCa)在内的各种实体恶性肿瘤有关,其存在似乎为肿瘤根除疗法的失败提供了解释。由于CSCs被认为与正常干细胞具有许多共同特性,了解正常干细胞应有助于阐明癌症的发病机制,重要的是,有助于了解潜在的治疗干预措施。本文的目的是综述PCa中CSCs的现有数据、其假定的表型标志物、在肿瘤生物学中的潜在作用以及与治疗的相关性。